Close

Home Page

Company Database

Licensing Deals

Database provided by

Featured company

MerLion Pharmaceuticals Pte Ltd
MerLion Pharmaceuticals Pte Ltd

Partners



Your source for recent licensing deal information

Knowledge about past deals is a crucial prerequisite for successful licensing negotiations. With a subscription to the Biotechgate Licensing Deals database you get online access to a comprehensive directory of therapeutic licensing deals with financial information from 1996 until today. As an alternative individual deal reports on specific big pharma companies, indications and development stages are offered.
 

Targeted Deal Benchmark Reports

Buy your set of individual reports (e.g. based on specific indications, Pharma companies or product development stage)

Targeted Deal Benchmark Reports

Are you interested to out-licence your new compound? Our targeted licensing deal reports provide you with key information to get the most value out of your next licensing deal:

  • Cross reference with comparable deals
  • Identify creative deal structures
  • Follow deal making trends in your therapy area of interest
  • Gain insight into how big pharma structure their licensing deals
  • All deals include at least one financial information component (deal size, upfront, milestone, royalty, equity, research funding)

Available Deal Benchmark Reports

Click on a link below to learn more about the report:

You cannot find what you are looking for? Please contact us for a tailor-made Deal Benchmark Report:
Phone: + 41 (44) 500 38 48
E-mail: support@biotechgate.com


Oncology deals  

 Specification Order # Min. no. of deals* Price EUR**
Early stage oncology deals OC-10 77 890.-
Phase I oncology deals OC-20 54 890.-
Phase II oncology deals OC-30 43 890.-
Phase III oncology deals OC-50 44 890.-
Oncology - antibody deals OC-60 74 890.-
Leukemia, lymphoma & multiple myeloma deals OC-70 62 890.-
Prostate cancer OC-80 30 890.-

or buy access to all deals - click here to learn more »
 
Click the "Order now" button to order a report by downloading the order form and submitting the signed form to us (by fax or e-mail, see address specified at the bottom of the document). You will then receive an invoice and once this is paid you will receive the ordered report.


Big pharma deals  

 Licensee Order # Min. no. of deals* Price EUR**
Astellas Pharma BP-10 26 590.-
Boehringer Ingelheim BP-20 26 590.-
BristolMyers Squibb BP-30 63 890.-
GlaxoSmithKline BP-40 108 890.-
Johnson & Johnson BP-50 53 890.-
Merck & Co BP-60 98 890.-
Novartis BP-70 78 890.-
Pfizer BP-80 115 890.-
Roche BP-90 81 890.-
Sanofi BP-100 82 890.-
Takeda Pharmaceutical Co BP-110 59 890.-

or buy access to all deals - click here to learn more »
 
Click the "Order now" button to order a report by downloading the order form and submitting the signed form to us (by fax or e-mail, see address specified at the bottom of the document). You will then receive an invoice and once this is paid you will receive the ordered report.


Early stage license deals  

 Disease area Order # Min. no. of deals* Price EUR**
Nervous system ES-10 40 590.-
Infections ES-20 51 890.-

or buy access to all deals - click here to learn more »
 
Click the "Order now" button to order a report by downloading the order form and submitting the signed form to us (by fax or e-mail, see address specified at the bottom of the document). You will then receive an invoice and once this is paid you will receive the ordered report.


Deals by indication outside oncology field  

 Indication Order # Min. no. of deals* Price EUR**
Alzheimer & Parkinson IN-10 51 890.-
Drug delivery IN-20 77 890.-
Eye disorders IN-30 42 890.-
Hepatitis B & C IN-50 43 890.-
Pain IN-60 63 890.-
Rheumatoid Arthritis IN-70 38 890.-

or buy access to all deals - click here to learn more »
 
Click the "Order now" button to order a report by downloading the order form and submitting the signed form to us (by fax or e-mail, see address specified at the bottom of the document). You will then receive an invoice and once this is paid you will receive the ordered report.


 
*minimum number of indicated deals. As we are constantly up-dating, you will get all the available deals in this category (count based on April 2013)
 
**excl. VAT/MWSt of 8.0% (applied to Swiss customers only)